Product
DeepTag-GPRC5D Targeted CAR T-cells
1 clinical trial
1 indication
Indication
Relapse/Refractory Multiple MyelomaClinical trial
A Study of DeepTag-GPRC5D Targeted CAR-T Cells Therapy for Refractory/Relapsed Multiple MyelomaStatus: Recruiting, Estimated PCD: 2026-10-20